TGFB1 and breast cancer: Although our results are consistent with previous reports of anti-metastatic activity of individual TGF-β antagonists in in vivo breast cancer models, none of the previous studies have conducted a comparison between two different pharmacological strategies to inhibit TGF-β signaling.